Install
FirstWord
- 110articles · 30d
- 2+ hour agolatest article
- Aug 14, 2026earliest in window
- 0%with images
- 13avg words
- Medical 89
- Health 73
- Health & Wellness 65
- Business & Industrial 40
- Economy, Business & Finance 25
- Finance & Business 17
- Science & Technology 10
- News 4
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
AstraZeneca's oral SERD stumbles in Phase III first-line breast cancer trial
2+ hour, 55+ min ago (12+ words) firstwordpharma.com...
Friday Five??? Novartis' stumbles spark boardroom backlash, Nodthera name drops, FDA throws wrench into Biohaven deal???and more
2+ day, 8+ hour ago (19+ words) Friday Five – Novartis' stumbles spark boardroom backlash, Nodthera name drops, FDA throws wrench into Biohaven deal…and more firstwordpharma.com...
AbbVie aims to expand Qulipta's label into new migraine market
2+ day, 9+ hour ago (12+ words) FirstWord PHARMA...
NodThera rebrands as Rezera, charts registrational path for PAD drug
3+ day, 2+ hour ago (12+ words) FirstWord Pharma...
Physician Views Results: Neurologists express cautious optimism for BTK inhibitors in MS
3+ day, 20+ hour ago (14+ words) FirstWord Pharma...
TwoStep's take on targeting solid tumours gains backing from Merck KGaA, Pfizer venture arms
3+ day, 16+ hour ago (16+ words) FirstWord Pharma...
Beeline buzzes ahead to pivotal lupus trials after mid-stage success
3+ day, 15+ hour ago (12+ words) FirstWord Pharma...
Inhibrx touts HNSCC subgroup data, eyes accelerated pathway for OX40 agonist
4+ day, 9+ hour ago (13+ words) FirstWord Pharma...
AI analysis from Brainomix adds to evidence backing Endeavor's IPF therapy
4+ day, 12+ hour ago (13+ words) FirstWord PHARMA...
Pharvaris' oral HAE hopeful significantly cuts attacks in pivotal study
4+ day, 14+ hour ago (12+ words) FirstWord PHARMA...